Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
How effective is the treatment with Brigatinib (Alunbrig)?A pivotal clinical study of brigatinib enrolled a total of 275 patients with ALK-positive NSCLC that had spread to other p···【more】
Article source：Captain MedicineRelease date：2026-05-21Recommended：2
Mechanism of Action of Brigatinib (Alunbrig)Brigatinib (Alunbrig) is an oral prescription targeted therapy drug belonging to the class of tyrosine kinase inhibitors (TKIs). It work···【more】
Article source：Captain MedicineRelease date：2026-05-21Recommended：3
Recommended Dosage and Administration of CrizotinibThe recommended dosage for adults with non-small cell lung cancer is 250 mg (one capsule) each time, taken twice daily (morning a···【more】
Article source：Captain MedicineRelease date：2026-05-20Recommended：24
Drug Interaction Risks of Crizotinib with Other MedicationsCrizotinib has many drug interactions that may increase side effects or reduce efficacy. Medications to avoid include cer···【more】
Article source：Captain MedicineRelease date：2026-05-20Recommended：19
Absolute Contraindications and Allergic Reactions to CrizotinibCrizotinib is contraindicated in the following situations: hypersensitivity to crizotinib or any other ingredients in···【more】
Article source：Captain MedicineRelease date：2026-05-20Recommended：21
Overview and Mechanism of Action of CrizotinibCrizotinib is a prescription medicine used to treat cancer, with its active ingredient being crizotinib. The drug works by inhibiting ···【more】
Article source：Captain MedicineRelease date：2026-05-20Recommended：20
Common side effects of Crizotinib and daily precautionsThe most common side effect in adult NSCLC patients taking Crizotinib is visual changes, which occur 4 to 7 times per week in···【more】
Article source：Captain MedicineRelease date：2026-05-19Recommended：17
Indications for CrizotinibCrizotinib is a prescription medication used to treat non-small cell lung cancer (NSCLC) caused by defects in the anaplastic lymphoma kinase (ALK) gene or···【more】
Article source：Captain MedicineRelease date：2026-05-19Recommended：22
Is Crizotinib Effective in Treating Cancer?In a clinical study of patients with ALK-positive metastatic NSCLC, 172 received crizotinib and 171 received standard chemotherapy. Resul···【more】
Article source：Captain MedicineRelease date：2026-05-19Recommended：27
Common and Serious Side Effects of RitlecitinibLike other medications, ritlecitinib may cause side effects, but not everyone experiences them. Serious side effects require your clo···【more】
Article source：Captain MedicineRelease date：2026-05-18Recommended：29
How to take Ritlecitinib correctlyAlways take Ritlecitinib exactly as directed by your doctor. The recommended dose is 50 mg once daily, taken orally. Swallow the capsule whole wit···【more】
Article source：Captain MedicineRelease date：2026-05-18Recommended：48
When should Ritlecitinib NOT be used?Before starting treatment with Ritlecitinib, the following conditions must be ruled out: you are absolutely prohibited from using Ritlecitinib ···【more】
Article source：Captain MedicineRelease date：2026-05-18Recommended：34
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：3502025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：5512024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：3362025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：3522025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：3272025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：3932025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3262025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：3012025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
